• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯里兰卡西部早期奥密克戎毒株簇内新冠病毒感染的基因组和人口统计学特征

Genomic and demographic characterization of SARS-CoV-2 infections within early Omicron cluster, Western Sri Lanka.

作者信息

Arachchige Nipuni, Dharmasiri Ramesha, Weerathunga Achini, Senanayake Shehan, Janage Nadeeka, Muthugala Rohitha

机构信息

Department of Molecular Biology, Medical Research Institute, Colombo 00800, Western, Sri Lanka.

Department of Virology, Ashford and St Peter's Hospitals Foundation Trust, Chertsey KT16, United Kingdom.

出版信息

World J Virol. 2025 Jun 25;14(2):106108. doi: 10.5501/wjv.v14.i2.106108.

DOI:10.5501/wjv.v14.i2.106108
PMID:40575635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12188914/
Abstract

BACKGROUND

The emergence of the Omicron variant (B.1.1.529) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raised global concerns with its highly transmissible nature.

AIM

To investigate the genomic, clinical, and demographic characteristics of Omicron infections within the early outbreak cluster in western part of Sri Lanka.

METHODS

We analyzed sequence data from January 2022 to April 2022 to understand variant dynamics, clinical presentation, and demographic associations.

RESULTS

Whole-genome sequencing of 85 nasopharyngeal and throat swab samples collected in western part of Sri Lanka between January and April 2022 identified 70 (82.34%) of it as Omicron variants. BA.2 was the most prevalent sub-lineage (57%), followed by BA.1.1 (14.20%) and majority of them were from > 12 years old individuals. Phylogenetic analysis revealed clustering into four distinct clades (21I, 21K, 21L, and 21M), suggesting potential differences in transmission chains or evolutionary pressures.

CONCLUSION

This study found BA.2 to be the predominant Omicron sub-lineage in the western part of Sri Lanka during the first quarter of 2022, aligning with global trends. Phylogenetic analysis revealed diverse introductions and local transmission. Continued genomic surveillance and robust public health measures remain crucial for managing the evolving SARS-CoV-2 landscape.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种(B.1.1.529)的出现因其高传播性引发了全球关注。

目的

调查斯里兰卡西部早期疫情聚集区内奥密克戎感染的基因组、临床和人口统计学特征。

方法

我们分析了2022年1月至2022年4月的序列数据,以了解变种动态、临床表现和人口统计学关联。

结果

对2022年1月至4月在斯里兰卡西部采集的85份鼻咽和咽喉拭子样本进行全基因组测序,确定其中70份(82.34%)为奥密克戎变种。BA.2是最常见的亚谱系(57%),其次是BA.1.1(14.20%),且大多数来自12岁以上个体。系统发育分析显示分为四个不同的进化枝(21I、21K、21L和21M),表明传播链或进化压力可能存在差异。

结论

本研究发现BA.2是2022年第一季度斯里兰卡西部主要的奥密克戎亚谱系,与全球趋势一致。系统发育分析揭示了多种引入和本地传播情况。持续的基因组监测和强有力的公共卫生措施对于应对不断演变的SARS-CoV-2形势仍然至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6201/12188914/c352d9c06ffa/wjv-14-2-106108-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6201/12188914/ff23994a403d/wjv-14-2-106108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6201/12188914/c352d9c06ffa/wjv-14-2-106108-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6201/12188914/ff23994a403d/wjv-14-2-106108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6201/12188914/c352d9c06ffa/wjv-14-2-106108-g005.jpg

相似文献

1
Genomic and demographic characterization of SARS-CoV-2 infections within early Omicron cluster, Western Sri Lanka.斯里兰卡西部早期奥密克戎毒株簇内新冠病毒感染的基因组和人口统计学特征
World J Virol. 2025 Jun 25;14(2):106108. doi: 10.5501/wjv.v14.i2.106108.
2
Alpha to JN.1 variants: SARS-CoV-2 genomic analysis unfolding its various lineages/sublineages evolved in Chhattisgarh, India from 2020 to 2024.从阿尔法到JN.1变体:2020年至2024年在印度恰蒂斯加尔邦进化出的SARS-CoV-2基因组分析揭示了其各种谱系/亚谱系。
World J Virol. 2025 Jun 25;14(2):100001. doi: 10.5501/wjv.v14.i2.100001.
3
Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya.高分辨率熔解分析在布基纳法索和肯尼亚监测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体中的应用。
mSphere. 2025 Jun 25;10(6):e0002725. doi: 10.1128/msphere.00027-25. Epub 2025 May 29.
4
Changes in Population Immunity to Omicron SARS-CoV-2 Variants and Selected Sarbecoviruses From 2020 to 2023 in Urban Colombo, Sri Lanka.2020年至2023年期间,斯里兰卡科伦坡市人群对奥密克戎SARS-CoV-2变体和选定的沙贝病毒的免疫力变化。
J Med Virol. 2025 Jul;97(7):e70462. doi: 10.1002/jmv.70462.
5
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
6
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.
7
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
8
Evolutionary dynamics of heparan sulfate utilization by SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对硫酸乙酰肝素的利用的进化动力学
mBio. 2025 Jun 23:e0130325. doi: 10.1128/mbio.01303-25.
9
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

本文引用的文献

1
Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies.奥密克戎变异株感染和严重事件的 SARS-CoV-2 疫苗有效性:基于检测阴性设计研究的系统评价和荟萃分析。
Front Public Health. 2023 Jun 9;11:1195908. doi: 10.3389/fpubh.2023.1195908. eCollection 2023.
2
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.丹麦关注的 SARS-CoV-2 奥密克戎变体 BA.1 和 BA.2 亚变体的家庭传播。
Nat Commun. 2022 Sep 30;13(1):5760. doi: 10.1038/s41467-022-33498-0.
3
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
奥密克戎变异株(B.1.1.529)及其亚谱系:在 SARS-CoV-2 重组变异株出现之际,我们目前了解多少?
Biomed Pharmacother. 2022 Oct;154:113522. doi: 10.1016/j.biopha.2022.113522. Epub 2022 Aug 15.
4
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.奥密克戎亚系的起源、病毒学特征、免疫逃逸与干预。
Signal Transduct Target Ther. 2022 Jul 19;7(1):241. doi: 10.1038/s41392-022-01105-9.
5
Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.Omicron (BA.1)及其子变体(BA.1.1、BA.2 和 BA.3)对 SARS-CoV-2 刺突的感染性和致病性:基于序列和结构的比较计算评估。
J Med Virol. 2022 Oct;94(10):4780-4791. doi: 10.1002/jmv.27927. Epub 2022 Jun 16.
6
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.SARS-CoV-2 奥密克戎 BA.2 刺突的病毒学特征。
Cell. 2022 Jun 9;185(12):2103-2115.e19. doi: 10.1016/j.cell.2022.04.035. Epub 2022 May 2.
7
SARS-CoV-2 Omicron variant: recent progress and future perspectives.SARS-CoV-2 奥密克戎变异株:最新进展与未来展望。
Signal Transduct Target Ther. 2022 Apr 28;7(1):141. doi: 10.1038/s41392-022-00997-x.
8
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
9
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.抗体和抗病毒药物对新冠病毒奥密克戎变异株的疗效
N Engl J Med. 2022 Mar 10;386(10):995-998. doi: 10.1056/NEJMc2119407. Epub 2022 Jan 26.
10
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.新冠病毒疫苗对轻症和重症疾病的保护持续时间。
N Engl J Med. 2022 Jan 27;386(4):340-350. doi: 10.1056/NEJMoa2115481. Epub 2022 Jan 12.